Molecular imaging in Parkinson's disease / / Cristina Polito.
The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients by means of molecular imaging techniques. Thirty-one consecutive drug-naïve PD patients from the Neurological Clinic of the University of Flor-ence underwent clinical assessment, neuropsychologi...
Saved in:
| VerfasserIn: | |
|---|---|
| Place / Publishing House: | Firenze : : Firenze University Press,, 2011. |
| Year of Publication: | 2011 |
| Language: | English |
| Physical Description: | 1 online resource (68 pages) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The present work explores brain functional changes in drug-naïve Parkinson's disease (PD) patients by means of molecular imaging techniques. Thirty-one consecutive drug-naïve PD patients from the Neurological Clinic of the University of Flor-ence underwent clinical assessment, neuropsychological assessment, MRI, [123I]FP-CIT SPECT, [18F]FDG PET. First, [18F]FDG-PET was employed to identify in drug-naïve PD patients brain metabolic alteration uniquely related to disease process and not modulated by anti-parkinsonian therapeutic intervention. Second, [18F]FDG-PET and [123I]FP-CIT SPECT were employed together to explore the early functional changes in brain function related to dopaminergic depletion in the putamen and in the caudate nucleus. |
|---|---|
| Hierarchical level: | Monograph |
| Statement of Responsibility: | Cristina Polito. |